CN Patent

CN120554386A — 新型吡啶并[1,2-a]嘧啶-4-酮衍生物、其制剂及制备方法

Assigned to F Hoffmann La Roche AG · Expires 2025-08-29 · 1y expired

What this patent protects

本发明涉及新型吡啶并[1,2‑a]嘧啶‑4‑酮衍生物、其制剂及制备方法。具体而言，本发明涉及一种制备用作药物活性化合物的7‑(4,7‑二氮杂螺[2.5]辛‑7‑基)‑2‑(2,8‑二甲基咪唑并[1,2‑b]哒嗪‑6‑基)吡啶并[1,2‑a]嘧啶‑4‑酮的方法。

USPTO Abstract

本发明涉及新型吡啶并[1,2‑a]嘧啶‑4‑酮衍生物、其制剂及制备方法。具体而言，本发明涉及一种制备用作药物活性化合物的7‑(4,7‑二氮杂螺[2.5]辛‑7‑基)‑2‑(2,8‑二甲基咪唑并[1,2‑b]哒嗪‑6‑基)吡啶并[1,2‑a]嘧啶‑4‑酮的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN120554386A
Jurisdiction
CN
Classification
—
Expires
2025-08-29
Drug substance claim
No
Drug product claim
No
Assignee
F Hoffmann La Roche AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.